Cat Flea

Main information

  • Trade name:
  • Cat Flea Collar with dimpylate 15% w/w
  • Pharmaceutical form:
  • Collar
  • Prescription type:
  • AVM-GSL - Authorised Veterinary Medicine – General Sales List
  • Medicine domain:
  • Animals
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • Cat Flea Collar with dimpylate 15% w/w
    United Kingdom
  • Language:
  • English

Therapeutic information

  • Therapeutic group:
  • Cats
  • Therapeutic area:
  • Ectoparasiticide

Other information

Status

  • Source:
  • VMD - Veterinary Medicines Directorate
  • Authorization status:
  • Authorized
  • Authorization number:
  • 00715/4113
  • Authorization date:
  • 27-08-2010
  • Last update:
  • 21-12-2016

Summary of Product characteristics

AN: 00884/2013

Revised: October 2013

SUMMARY OF PRODUCTS CHARACTERISTICS

1. NAME OF THE VETERINARY MEDICINAL PRODUCT

Cat Flea Collar with Dimpylate 15% w/w

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Active substance                                                                                   % w/w                  mg/collar

Dimpylate (as dimpylate stabilised) 15.0 2,100

Excipients                                                                                                 % w/w                  mg/collar

Brown collar:  Ferric oxide red (E172) 0.08 11.2

Charcoal, vegetable (E153) 0.02            2.8

For full list of excipients, see section 6.1

3. PHARMACEUTICAL FORM

Collar.

Coloured flea collar fitted with safety buckle.

4. CLINICAL PARTICULARS

4.1 Target species

Cats.

4.2 Indications for use, specifying the target species

Treatment of cats infested with fleas (Ctenocephalides felis).

4.3 Contraindications

No other insecticide should be used with the collar or within 7 days of removal.

Do not allow the collar to come into contact with nursing females.

Do not use the collar on cats younger than 6 months. 

4.4 Special warnings for each target species

Remove collar if any sign of skin irritation occurs.

Check the collar is not too tight, to ensure against irritation.

Do not allow animals to chew the collar.

Remove collar from cat immediately should any signs of drowsiness, listlessness or 

respiratory difficulties develop soon after fixing the collar.

Page 1 of 5

AN: 00884/2013

Revised: October 2013

4.5 Special precautions for use

i. Special precautions for use in animals

For external use only.

Remove fleas from young kittens and nursing females by careful use of a flea 

comb.

ii. Special precautions for the person administering the veterinary medicinal 

product to animals

Do not remove collar from pack until ready to use.

Do not allow children to play with the collar.

Do not allow children to suck or chew the collar.

Do not smoke, eat or drink while handling collar.

Do not sleep with pets wearing collars.

Dimpylate / Diazinon is an organophosphorus compound: DO NOT handle if 

under medical advice not to work with ANTICHOLINESTERASES.

Avoid excessive handling of the collar.

Cut off any excess collar with scissors and dispose of safely.

If you feel unwell after handling the collar, seek medical advice. Wash hands 

thoroughly after handling the collar.

iii. Other precautions

To help prevent reinfestation, animals’ bedding and regular resting areas, 

including carpets and soft furnishings, should be treated with a suitable 

insecticide and vacuumed regularly.

4.6 Adverse reactions (frequency and seriousness)

Typical adverse reactions to organophosphorus compounds are rare.

4.7 Use during pregnancy, lactation or lay

Do not allow contact with nursing females.

4.8 Interaction with other medicinal products and other forms of interaction

Do not combine with other organophosphorus compounds or medicines which are not 

compatible with organophosphorus compounds.

4.9 Amount(s) to be administered and administration route

One collar per animal to be fastened around the neck. Fasten the collar around the 

cat’s neck, ensuring a comfortable fit; two fingers should fit easily under the collar. 

Loosen the collar as the cat grows. Cut off excess collar extending beyond buckle and

dispose of with the household refuse. Replace collar every 4 months if re-infestation is

a risk.

Page 2 of 5

AN: 00884/2013

Revised: October 2013

Page 3 of 5

AN: 00884/2013

Revised: October 2013

4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary

Symptoms: Tearing, salivation, muscle twitches, vomiting, loss of 

reflexes, coma, cyanosis.

Emergency procedure:  Remove collar.

Antidote: Atropine.

4.11 Withdrawal period

Not applicable.

5. PHARMACOLOGICAL PROPERTIES

Pharmacotherapeutic group: Ectoparasiticides for topical use, incl. insecticides.

ATC Vet Code: QP53AF03

5.1 Pharmacodynamic properties

The collar is applied around the cat’s neck. The collar constantly releases dimpylate 

over a four month period. Fleas on the skin of the animal come into contact with the 

dimpylate and are killed.

5.2 Pharmacokinetic properties

Dimpylate is an organophosphorus compound with a non-systemic action.

5.3 Environmental properties

6. PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Charcoal Vegetable (E153)

Ferric Oxide Red (E172)

Polyvinyl chloride

Dibutyl phthalate

Epoxidised Soya Bean Oil

Calcium Stearate

6.2 Incompatibilities

Morphine, theophylline, aminophylline, large amounts of intravenous fluids, 

phenothiazine drugs, pyrantel palmoate.

Page 4 of 5

AN: 00884/2013

Revised: October 2013

6.3 Shelf life

Shelf life of the veterinary medicinal product as packaged for sale: 2 years.

6.4 Special precautions for storage

Protect from direct sunlight.

Do not store above 25°C.

Do not remove the collar from the pack until you are ready to fit it.

6.5 Nature and composition of immediate packaging

Paper/aluminium foil/low density polyethylene sachet, containing one PVC collar.

6.6 Special precautions for the disposal of unused veterinary medicinal product or 

waste materials derived from the use of such products, if appropriate

Any unused veterinary medicinal product or waste materials derived from such 

veterinary medicinal products should be disposed of in accordance with local 

requirements.

EXTREMELY DANGEROUS to fish and aquatic life. 

Do not contaminate ponds, waterways or ditches with the collar or empty packaging.

7 MARKETING AUTHORISATION HOLDER

Bob Martin (UK) Ltd.

Wemberham Lane

Yatton

Somerset

BS49 4BS

U.K.

8. MARKETING AUTHORISATION NUMBER

Vm:

 00715/4113

9. DATE OF FIRST AUTHORISATION

Date: 27 August 2010

10. DATE OF REVISION OF THE TEXT

Date: October 2013

Approved: 11/10/2013

Page 5 of 5

Document Outline

24-5-2018

FDA Approves Semintra, the First FDA-approved Animal Drug for the Control of Systemic Hypertension in Cats

FDA Approves Semintra, the First FDA-approved Animal Drug for the Control of Systemic Hypertension in Cats

The FDA has approved Semintra (telmisartan oral solution), the first FDA-approved animal drug to control systemic hypertension in cats. Semintra is an oral solution administered either directly into the cat’s mouth or on top of a small amount of food.

FDA - U.S. Food and Drug Administration

11-1-2018

Is My Dog or Cat a Healthy Weight? Important Questions to Ask the Vet

Is My Dog or Cat a Healthy Weight? Important Questions to Ask the Vet

Just as obesity has become a serious problem in people, it's also a growing problem in pets, one that can seriously harm your pet's health.

FDA - U.S. Food and Drug Administration

10-8-2017

Bravecto® may cause convulsions in dogs on rare occasions

Bravecto® may cause convulsions in dogs on rare occasions

The European Medicines Agency has reviewed the adverse events of Bravecto®, a veterinary medicine used to treat flea and tick infestations in dogs. The conclusion is that the medicine may on very rare occasions cause convulsions in dogs – primarily in dogs with pre-existing epilepsy.

Danish Medicines Agency

25-5-2018

Agenda:  Agenda - CAT agenda of the 23-25 May 2018 meeting

Agenda: Agenda - CAT agenda of the 23-25 May 2018 meeting

Europe - EMA - European Medicines Agency

2-5-2018

 Minutes of the CAT meeting 15-16 February 2018

Minutes of the CAT meeting 15-16 February 2018

Europe - EMA - European Medicines Agency